Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Swanson

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Urology|October 14, 2008
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomyWassim Kassouf, Piyush K Agarwal, H Barton Grossman, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 12, 2010
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapySteven J Frank, Ramesh C Tailor, Rajat J Kudchadker, et al.
BJU International|November 28, 2006
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?Gordon A Brown, J Erik Busby, Christopher G Wood, et al.
European Urology|September 12, 2008
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerJohn W Davis, David W Chang, Pierre Chevray, et al.
Practical Radiation Oncology|March 29, 2014
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapyHadley J Sharp, David A Swanson, Thomas J Pugh, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life OutcomesSteven J Frank, Thomas J Pugh, Pierre Blanchard, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experienceJean-Jacques Patard, Emmanuelle Leray, Nathalie Rioux-Leclercq, et al.
Brachytherapy|February 27, 2016
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costingNikhil G Thaker, Thomas J Pugh, Usama Mahmood, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Urology|October 14, 2008
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomyWassim Kassouf, Piyush K Agarwal, H Barton Grossman, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 12, 2010
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapySteven J Frank, Ramesh C Tailor, Rajat J Kudchadker, et al.
BJU International|November 28, 2006
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?Gordon A Brown, J Erik Busby, Christopher G Wood, et al.
European Urology|September 12, 2008
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerJohn W Davis, David W Chang, Pierre Chevray, et al.
Practical Radiation Oncology|March 29, 2014
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapyHadley J Sharp, David A Swanson, Thomas J Pugh, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life OutcomesSteven J Frank, Thomas J Pugh, Pierre Blanchard, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2014
Establishing high-quality prostate brachytherapy using a phantom simulator training programNikhil G Thaker, Rajat J Kudchadker, David A Swanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experienceJean-Jacques Patard, Emmanuelle Leray, Nathalie Rioux-Leclercq, et al.
Brachytherapy|February 27, 2016
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costingNikhil G Thaker, Thomas J Pugh, Usama Mahmood, et al.
Pageof 7